IntelliQuit is a brand that is committed to using state-of-the-art technology to combat the global tobacco pandemic and reduce its associated health risks. Their mission is to eliminate the morbidity and mortality caused by tobacco use while providing value for their customers and clinical partners. With a focus on evidence-based medical treatments, IntelliQuit offers a range of products and services to help individuals overcome tobacco addiction.

Their flagship product is the AI-powered, cloud-based nicotine testing platform, which allows healthcare professionals to accurately measure their patients' biochemical nicotine consumption in just 15 minutes. Unlike traditional methods of counting cigarettes or pods, this advanced technology provides lab-quality results that are both reliable and convenient. For the first time, tobacco addiction can be treated as a chronic condition, thanks to IntelliQuit's innovative solutions.

Along with the nicotine testing platform, they provide treatment solutions that include expert consultations from their world-renowned tobacco treatment experts. Their aim is to help healthcare professionals better understand their patients' results and tailor effective treatment plans. To further support quitting efforts, IntelliQuit has developed the My Nicotine Test Mobile App—a groundbreaking smartphone technology that measures nicotine consumption from all sources of tobacco and nicotine replacement.

This app assists individuals in switching, cutting down, or quitting by giving them valuable insights into their nicotine levels. The IntelliQuit brand is dedicated to transforming the way tobacco addiction is addressed, empowering individuals to take control of their health and well-being. With their cutting-edge products and services, they aim to make a positive impact on the lives of tobacco users and contribute to the global efforts in reducing smoking-related harm